Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of rhCu/Zn SOD on inflammation-induced impairment of vascular reactivity
2005-000744-82Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2005
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of recombinant human copper-zinc superoxide dismutase, sponsored by Medical University of Vienna. Primary endpoint: Plasma concentrations of rhSOD. Started May 2005; status: completed.
02
Drugs
recombinant human copper-zinc superoxide dismutase
Beyond the preview
Go deeper on 2005-000744-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000744-82.